Loading the security page…
The series is stated in the current share scale after splits; dividends are not included in the price
Clover Health Investments, Corp. (CLOV) is a public company in the healthcare sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2026-06-30, revenue was 2.5bn $, net income was -18.4m $. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Share count is a period average, so market cap is approximate.
Clover Health Investments, Corp. (CLOV) is a company in the Health care sector; its shares trade on Nasdaq.
The price of Clover Health Investments, Corp. (CLOV) on October 30, 2026 is 4.44 $, −3.06 % on the day. Over 52 weeks the stock traded between 1.58 $ and 5.59 $; the price now sits 71 % of the way up that range. Over the past year the price changed by +65.93 %. Market capitalization is 2.42 billion $, rank 8 among 9 stocks of the same industry with a known capitalization.
Clover Health Investments, Corp. trades on Nasdaq under the ticker CLOV. The company belongs to the Health care sector. The trading history on this page starts on 12 June 2020.
Over the past 52 weeks CLOV has traded between 1.58 $ and 5.59 $. As of 30 October 2026 the price stood 72.32 % of the way from the 52-week low to the high.
Over one year CLOV shares rose 65.93 %; over six months they rose 104.57 %. Volatility over 90 days is 59.25 %. Dividends are not included: this is price change only, as of 30 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 1.0, below the sector median of 3.6. Price to book is 6.4, above the sector median of 2.5. Calculated from reports for the period ending 30 June 2026.
Clover Health Investments, Corp. reported revenue of 2.5B $ and a net loss of 18M $ over the last four quarters. Net margin is −0.74 %. Revenue changed by +54.03 % year over year. Earnings per share are −0.05 $. Market capitalisation is 2.4B $.
CLOV has a return on equity of −4.88 %, above the sector median of −40.58 %. Return on assets is −2.55 %, above the sector median of −30.08 %. Operating margin is −0.74 %, above the sector median of −20.96 %.